Al(OH)3 an Adjuvant

Aluminum adjuvants are used in vaccine manufacturing to “stimulate” the immune system The presence of aluminium adjuvants has been associated with injection-site reactions such as nodules, granulomas and erythema. aluminium adjuvants may lead to the syndrome macrophagic myofascitis, a histological finding where aluminium-containing macrophages infiltrate muscle tissue, and may be accompanied by a clinical syndrome of myalgia, arthralgia and fatigue. A systematic review of controlled safety studies reported that vaccines containing aluminium produce more erythema and induration than other vaccines in young children (up to 18 months of age), and greater local pain in older children (10–18 years).

EDF Suspected – cardiovascular or blood toxicant, neurotoxicant, respiratory toxicant, respiratory toxicant. Implicated as a cause of brain damage; suspected factor in Alzheimer’s Disease, dementia, convulsions and comas. More hazardous than most chemicals in 2 out of 6 ranking systems. On at least 2 federal regulatory lists. EDF Suspected – cardiovascular or blood toxicant neurotoxicant, respiratory toxicant. More hazardous than most chemicals in 3 out of 11 ranking systems. On at least 3 federal regulatory lists.

Chemical descriptions:

National Library of Medicine: PubChem

Adverse effects[Mesh%20Terms%3anoexp



Scorecard: Pollution Information Site

a.k.a. Hydrated alumina, Aluminum hydrate, Aluminum trihydrate, Di-Gel®, Riopan®